癌症登记软体市场规模、份额和成长分析（按类型、部署模型、资料库、功能、最终用户、区域）：产业预测（2024-2031）

2023年全球癌症登记软体市场规模预计为7067万美元，从2024年的7809万美元增长到2031年的1.7358亿美元，在预测期内（2024-2031年）增长10.5%，预计将以复合年增长率

由于对有效癌症管理、医疗品质提高和成本降低的需求不断增加，癌症登记软体市场正在显着增长。这种先进的资料库系统在组织、收集和储存患者资料以评估治疗结果方面发挥关键作用，这有助于改善资讯管理和对癌症登记资料的存取。越来越多地使用癌症患者登记资料进行市场监测以及电子健康记录(EHR) 的激增进一步推动了这一增长。此外，最近的产品核准和推出也有助于市场扩张。对工作流程优化和减少医生工作量的需求正在显着推动先进软体解决方案在医疗保健环境中的整合。政府对公共卫生的关注、对医疗基础设施的投资以及旨在遏制医疗成本上升的倡议都与市场的加速发展有关。此癌症登记解决方案的主要优势，包括简化的工作流程、自动化病例登记和癌症病例成长，预计将推动其采用。此外，各个政府机构正在积极推动癌症登记处的建立，这可能会推动市场成长。在预测期内，这些因素结合在一起，使癌症登记软体市场走上强劲的轨道，将其定位为现代医疗保健管理策略的重要组成部分。

目录

介绍

• 分析目的
• 定义
• 市场范围

分析方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• PESTEL分析
• 总体经济指标

全球癌症登记软体市场规模（按类型）/复合年增长率（2024-2031）

• 市场概况
• 独立软体
• 整合软体

全球癌症登记软体市场规模（依部署模式）/复合年增长率（2024-2031）

• 市场概况
• 本地
• 云端基础

全球癌症登记软体市场规模（按资料库）/复合年增长率（2024-2031）

• 市场概况
• 商业资料库
• 公共资料库

全球癌症登记软体市场规模（按功能）/复合年增长率（2024-2031）

• 市场概况
• 符合州和联邦法规的癌症报告
• 患者照护管理
• 产品性能评价
• 医学研究/临床研究

全球癌症登录软体市场规模（依最终用户）/复合年增长率（2024-2031）

• 市场概况
• 政府机构/TPA（第三方管理员）
• 医院/诊所
• 製药、生技和医疗设备公司
• 私人保险公司
• 研究中心

全球癌症登记软体市场规模/复合年增长率（2024-2031）

• 北美（按类型、部署模型、资料库、功能、最终用户）
  • 美国
  • 加拿大
• 欧洲（按类型、部署模型、资料库、功能、最终用户）
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家
• 亚太地区（按类型、部署模型、资料库、功能、最终用户）
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲（按类型、部署模型、资料库、功能、最终用户）
  • 巴西
  • 其他拉丁美洲
• 中东/非洲（按类型、部署模型、资料库、功能、最终用户）
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 年比收益成长（YoY）比较（2021-2023）

主要企业简介

• IBM Watson Health
• Oracle Corporation
• Siemens Healthineers
• Cerner Corporation
• Epic Systems Corporation
• MEDITECH
• Allscripts Healthcare Solutions
• McKesson Corporation
• Philips Healthcare
• GE Healthcare
• Inova Health System
• Varian Medical Systems
• Roche Diagnostics
• TomoTherapy Inc.
• Health Information Systems
• Elekta
• ONCO, Inc.
• Conduent, Inc.
• Ordinate Corporation
• Volpara Health Limited

结论和建议

Global Cancer Registry Software Market size was valued at USD 70.67 Million in 2023 poised to grow from USD 78.09 Million in 2024 to USD 173.58 Million by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

The cancer registry software market is experiencing significant growth driven by the increasing demand for effective cancer management, enhanced healthcare quality, and reduced costs. This sophisticated database system plays a crucial role in organizing, collecting, and preserving patient data to evaluate treatment outcomes, thus fostering better information management and access to cancer registry data. The rise in the utilization of cancer patient registry data for market surveillance and the widespread adoption of Electronic Health Records (EHRs) further fuel this growth. Additionally, recent product approvals and launches contribute to market expansion. The demand for optimized workflows and the alleviation of physician workloads are substantially driving the integration of advanced software solutions in healthcare settings. Factors such as governmental focus on population health, investments in healthcare infrastructure, and initiatives aimed at controlling rising healthcare expenses correlate with an accelerated development of the market. Key benefits of these cancer registry solutions, including streamlined workflows, automated case registries, and the increase in cancer cases, are anticipated to bolster their adoption. Moreover, various governmental organizations are actively promoting the establishment of cancer registries, which is likely to expedite market growth. As we move through the projection period, the combination of these factors suggests a robust trajectory for the cancer registry software market, positioning it as an essential component of modern healthcare management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cancer Registry Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cancer Registry Software Market Segmental Analysis

Global Cancer Registry Software Market is segmented by Type, Deployment Model, Database, Functionality, end user and region. Based on Type, the market is segmented into Standalone Software, Integrated Software. Based on Deployment Model, the market is segmented into On-premises, Cloud-based. Based on Database, the market is segmented into Commercial Databases, Public Databases. Based on Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, Medical Research and Clinical Studies. Based on end user, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cancer Registry Software Market

The increasing focus on enhancing population health management and the efficient exchange of health information is a significant market driver for the Global Cancer Registry Software market. Governments worldwide are actively promoting the establishment of cancer registries to combat rising cancer incidence rates, with many agencies investing in digitization initiatives and the development of computerized illness registries. By facilitating real-time data collection and analysis, these software solutions enable better management of cancer care, resource allocation, and targeted public health strategies. As a result, the push for improved governmental healthcare systems is fueling demand for advanced cancer registry software solutions.

Restraints in the Global Cancer Registry Software Market

One of the significant market restraints for the Global Cancer Registry Software market is the increasing concern over data privacy and security. With family member information often intertwined with patient health data, the risk of data breaches poses a critical threat to confidentiality. Such incidents can lead to sensitive information falling into unauthorized hands, raising ethical and legal implications. Governments in developed economies are struggling to establish regulations that adequately protect privacy while promoting data accessibility for research and healthcare improvement. This regulatory uncertainty can slow software adoption and deter potential investments, thus hindering market growth in the cancer registry sector.

Market Trends of the Global Cancer Registry Software Market

The global cancer registry software market is witnessing a robust trend towards comprehensive data management coupled with increased global adoption, driven by the escalating need for precise cancer analytics in healthcare systems. Hospitals are increasingly integrating advanced registry software solutions to streamline the collection, processing, and organization of cancer-related patient data. This shift enhances the quality of oncology care, enabling healthcare providers to glean insights for better treatment protocols and resource allocation. Moreover, rising awareness of cancer epidemiology, coupled with regulatory support for cancer data reporting, is substantially propelling the demand for efficient and adaptable cancer registry systems worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators

Global Cancer Registry Software Market Size by Type & CAGR (2024-2031)

• Market Overview
• Standalone Software
• Integrated Software

Global Cancer Registry Software Market Size by Deployment Model & CAGR (2024-2031)

• Market Overview
• On-premises
• Cloud-based

Global Cancer Registry Software Market Size by Database & CAGR (2024-2031)

• Market Overview
• Commercial Databases
• Public Databases

Global Cancer Registry Software Market Size by Functionality & CAGR (2024-2031)

• Market Overview
• Cancer Reporting to Meet State & Federal Regulations
• Patient Care Management
• Product Outcome Evaluation
• Medical Research and Clinical Studies

Global Cancer Registry Software Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Government Organizations & Third-party Administrators (TPAS)
• Hospitals & Medical Practices
• Pharmaceutical, Biotechnology, & Medical Device Companies
• Private Payers
• Research Centers

Global Cancer Registry Software Market Size & CAGR (2024-2031)

• North America, (Type, Deployment Model, Database, Functionality, End-User)
  • US
  • Canada
• Europe, (Type, Deployment Model, Database, Functionality, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Deployment Model, Database, Functionality, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Deployment Model, Database, Functionality, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Deployment Model, Database, Functionality, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDITECH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Health System
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TomoTherapy Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Information Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ONCO, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conduent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ordinate Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volpara Health Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation